title: Viral and Synthetic RNA Vector Technologies and Applications.
abstract: Use of RNA is an increasingly popular method to transiently deliver genetic information for cell manipulation in basic research and clinical therapy. In these settings, viral and nonviral RNA platforms are employed for delivery of small interfering RNA and protein-coding mRNA. Technological advances allowing RNA modification for increased stability, improved translation and reduced immunogenicity have led to increased use of nonviral synthetic RNA, which is delivered in naked form or upon formulation. Alternatively, highly efficient viral entry pathways are exploited to transfer genes of interest as RNA incorporated into viral particles. Current viral RNA transfer technologies are derived from Retroviruses, nonsegmented negative-strand RNA viruses or positive-stranded Alpha- and Flaviviruses. In retroviral particles, the genes of interest can either be incorporated directly into the viral RNA genome or as nonviral RNA. Nonsegmented negative-strand virus-, Alpha- and Flavivirus-derived vectors support prolonged expression windows through replication of viral RNA encoding genes of interest. Mixed technologies combining viral and nonviral components are also available. RNA transfer is ideal for all settings that do not require permanent transgene expression and excludes potentially detrimental DNA integration into the target cell genome. Thus, RNA-based technologies are successfully applied for reprogramming, transdifferentiation, gene editing, vaccination, tumor therapy, and gene therapy.
authors.affiliation: Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.|Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany.
authors.forename: Juliane W
authors.initials: JW
authors.lastname: Schott
authors.affiliation: Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.|Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Morgan
authors.affiliation: Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.|Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany.
authors.forename: Melanie
authors.initials: M
authors.lastname: Galla
authors.affiliation: Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.|Cluster of Excellence REBIRTH, Hannover Medical School, Hannover, Germany.|Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
authors.forename: Axel
authors.initials: A
authors.lastname: Schambach
mesh_terms: D000818:Animals; D001709:Biotechnology; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D005818:Genetic Engineering; D005822:Genetic Vectors / Q000235:genetics*; D006801:Humans; D012313:RNA / Q000138:chemical synthesis* / Q000737:chemistry / Q000235:genetics*; D014779:Virus Replication; D014780:Viruses / Q000145:classification / Q000235:genetics*
chemical_list: D012313:RNA